GenTrust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GenTrust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.7M	Sell	175,143 -520	-0.3%	-$70.3K	1.06%	23
2026 Q1	$22.4M	Hold	175,663	–	–	0.96%	23
2025 Q4	$21.4M	Buy	175,663 +143	+0.1%	+$16.4K	0.92%	24
2025 Q3	$17.6M	Sell	175,520 -13,301	-7%	-$1.2M	0.8%	28
2025 Q2	$15.7M	Sell	188,821 -851	-0.4%	-$67.9K	0.74%	31
2025 Q1	$15.4M	Buy	189,672 +280	+0.1%	+$25K	0.74%	28
2024 Q4	$17.1M	Sell	189,392 -178	-0.1%	-$17.2K	0.74%	32
2024 Q3	$18.7M	Sell	189,570 -1,034	-0.5%	-$102K	0.92%	21
2024 Q2	$17.7M	Sell	190,604 -3,951	-2%	-$354K	0.96%	20
2024 Q1	$18.5M	Sell	194,555 -8,079	-4%	-$750K	1.14%	19
2023 Q4	$18.1M	Sell	202,634 -218,883	-52%	-$16.3M	1.2%	18
2023 Q3	$30.8M	Sell	421,517 -76,288	-15%	-$6.09M	2.16%	12
2023 Q2	$41.4M	Buy	497,805 +13,515	+3%	+$1.13M	2.81%	10
2023 Q1	$36.9M	Buy	484,290 +116,877	+32%	+$9.7M	2.66%	10
2022 Q4	$30.5M	Buy	367,413 +66,892	+22%	+$5.42M	2.72%	10
2022 Q3	$23.8M	Buy	300,521 +10,465	+4%	+$882K	2.06%	12
2022 Q2	$21.5M	Buy	+290,056	New	+$21.8M	1.78%	16

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

GenTrust's XBI Position: Q2 2026 in Review

GenTrust reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.3% in Q2 2026, selling an estimated $70.3K and leaving 175,143 shares worth $27.7M. The position accounts for 1.06% of the portfolio, ranked #23.

GenTrust first reported a position in XBI in Q2 2022 and has held it in 17 quarters since. The position peaked at $41.4M in Q2 2023. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

GenTrust held 175,143 shares of State Street SPDR S&P Biotech ETF worth $27.7M as of Q2 2026.
GenTrust sold 520 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $70.3K.
State Street SPDR S&P Biotech ETF made up 1.06% of GenTrust's portfolio in Q2 2026, its #23 holding.
GenTrust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 17 quarters since.
GenTrust's State Street SPDR S&P Biotech ETF position peaked at $41.4M in Q2 2023.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on GenTrust's 13F filing for Q2 2026, filed 6 Aug 2026.